<?xml version="1.0" encoding="UTF-8"?>
<ref id="B97">
 <label>97.</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Cavalli</surname>
    <given-names>G</given-names>
   </name>
   <name>
    <surname>De Luca</surname>
    <given-names>G</given-names>
   </name>
   <name>
    <surname>Campochiaro</surname>
    <given-names>C</given-names>
   </name>
   <name>
    <surname>Della-Torre</surname>
    <given-names>E</given-names>
   </name>
   <name>
    <surname>Ripa</surname>
    <given-names>M</given-names>
   </name>
   <name>
    <surname>Canetti</surname>
    <given-names>D</given-names>
   </name>
   <etal/>
  </person-group>. 
  <article-title>Interleukin-1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: a retrospective cohort study</article-title>. 
  <source>Lancet Rheumatol.</source> (
  <year>2020</year>) 
  <volume>2</volume>:
  <fpage>e325</fpage>â€“
  <lpage>31</lpage>. 
  <pub-id pub-id-type="doi">10.1016/S2665-9913(20)30127-2</pub-id>
  <?supplied-pmid 32501454?>
  <pub-id pub-id-type="pmid">32501454</pub-id>
 </mixed-citation>
</ref>
